Advertisement

Effiziente Schwindeltherapie (nicht nur) im Alter

Conference paper
  • 1.3k Downloads

Zusammenfassung

Die Seniorenliga schätzt, dass etwa 10% aller Menschen in Deutschland von Schwindel betroffen sind, bei den über 60-Jährigen sollen es bereits 25% sein und bei den über 70-Jährigen über 50%. Angesichts der prognostizierten Alterspyramide ist leicht nachvollziehbar, dass Schwindel in der Zukunft ein zunehmend häufiges und relevantes Problem in der Geriatrie werden wird. Chronischer Schwindel im Alter ist somit in der ärztlichen Praxis allgegenwärtig.

Diese Übersichtsarbeit fokussiert auf die Schwindeltherapie im Alter und stellt die Grundlagen und die wesentlichen Erkrankungsbilder des peripheren und zentral-vestibulären Systems vor. Im Anschluss wird auf das spezifische Problem des „multimodalen Schwindels im Alter“ eingegangen, danach werden die wesentlichen Medikamente gegen Schwindel besprochen.

Literatur

  1. Babin RW, Harker LA (1982) The vestibular system in the elderly. Otolaryngol Clin North Am 15:387–393PubMedGoogle Scholar
  2. Bhattacharyya N, Baugh RF, Orvidas L, Barrs D, Bronston LJ, Cass S, Chalian AA, Desmond AL, Earll JM, Fife TD, Fuller DC, Judge JO, Mann NR, Rosenfeld RM, Schuring LT, Steiner RW, Whitney SL, Haidari J, American Academy of Otolaryngology-Head and Neck Surgery Foundation (2008) Clinical practice guideline: benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 139(4):47–81CrossRefGoogle Scholar
  3. Brandt T (1999) Vertigo. Its Multisensory Syndromes, 2. Aufl. Springer-Verlag, BerlinGoogle Scholar
  4. Brandt T, Bötzel K, Yousry T, Dieterich M, Schulze S (1995) Rotational vertigo in embolic stroke of the vestibular and auditory cortices. Neurology 45:42–44PubMedCrossRefGoogle Scholar
  5. Brandt T, Dieterich M, Strupp M (2013) Vertigo – Leitsymptom Schwindel, 2. Aufl. Springer Verlag, Berlin, HeidelbergCrossRefGoogle Scholar
  6. Claassen J, Feil K, Bardins S, Teufel J, Spiegel R, Kalla R, Schneider E, Jahn K, Schniepp R, Strupp M (2013) Dalfampridine in patients with downbeat nystagmus – an observational study. J Neurol 260:1992–1996 (Apr 16 Epub)PubMedCrossRefGoogle Scholar
  7. Dormann H, Sonst A, Müller F, Vogler R, Patapovas A, Pfistermeister B, Plank-Kiegele B, Kirchner M, Hartmann N, Bürkle T, Maas R (2013) Adverse Drug Events in Older Patients Admitted as an Emergency: The Role of Potentially Inappropriate Medication in Elderly People (PRISCUS). Dtsch Arztebl Int 110:213–219PubMedCentralPubMedGoogle Scholar
  8. Erbguth F (2006) Vaskulärer Schwindel im Alter. Europ J Geriatrics 8:100–104Google Scholar
  9. Ernst A (2011) Perspektiven der Gleichgewichtsdiagnostik und -therapie. Laryngo-Rhino-Otol 90:S35–S43CrossRefGoogle Scholar
  10. Gesundheitsberichterstattung des Bundes (Hrsg) (2009) Gesundheit und Krankheit im Alter. Berlin, Robert-Koch-Institut (www.rki.de)Google Scholar
  11. Glasauer S, Strupp M, Kalla R, Büttner U, Brandt T (2005) Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus. Ann NY Acad Sci 1039:528–531PubMedCrossRefGoogle Scholar
  12. Göbel H (2012) Die Kopfschmerzen, 3. Aufl. Springer Verlag, Berlin, HeidelbergCrossRefGoogle Scholar
  13. Grundstrom AC, Guse CE, Layde PM (2012) Risk factors for falls and fall-related injuries in adults 85 years of age and older. Arch Gerontol Geriatr 54:421–428PubMedCentralPubMedCrossRefGoogle Scholar
  14. Hamann KF (2009) Vestibulare Kompensation: Grundlagen und klinische Bedeutung. HNO 57:487–502PubMedCrossRefGoogle Scholar
  15. Helling K, Watanabe N, Jijiwa H, Mizuno Y, Watanabe S, Scherer H (2002) Altered cupular mechanics: a cause of peripheral vestibular disorders? Acta Otolaryngol 122:386–391PubMedCrossRefGoogle Scholar
  16. Herdman SJ, Schubert MC, Das VE, Tusa RJ (2003) Recovery of dynamic visual acuity in unilateral vestibular hypofunction. Arch Otolaryngol Head Neck Surg 129:819–824PubMedCrossRefGoogle Scholar
  17. Holt S, Schmiedl S, Thürmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107:543–551 (siehe auch www.priscus.net)PubMedCentralPubMedGoogle Scholar
  18. Hüfner K, Barresi D, Glaser M, Linn J, Adrion C, Mansmann U, Brandt T, Strupp M (2008) Vestibular paroxysmia: diagnostic features and medical treatment. Neurology 71:1006–1014PubMedCrossRefGoogle Scholar
  19. Hund M, Huber W (1991) Eye movement behaviour of patients with cerebral microangiopathy and macroangiopathy in simple visual detection tasks. Brain 114:1315–1321PubMedCrossRefGoogle Scholar
  20. Huppert D, Strupp M, Mückter H, Brandt T (2011) Which medication do I need to manage dizzy patients? Acta Otolaryngol 131:228–241PubMedCrossRefGoogle Scholar
  21. Huppert D, Strupp M, Rettinger N, Hecht J, Brandt T (2005) Phobic postural vertigo – a long-term follow-up (5 to 15 years) of 106 patients. J Neurol 252:564–569PubMedCrossRefGoogle Scholar
  22. Iro H, Waldfahrer F (2011) Vertigo – Kontroverses und Bewährtes. Springer, WienCrossRefGoogle Scholar
  23. Ishiyama G (2009) Imbalance and vertigo: the aging human vestibular periphery. Semin Neurol 29:491–499PubMedCrossRefGoogle Scholar
  24. Jang YS, Hwang CH, Shin JY, Bae WY, Kim LS (2006) Age-related changes on the morphology of the otoconia. Laryngoscope 116:996–1001PubMedCrossRefGoogle Scholar
  25. Jeong SH, Kim JS, Shin JW, Kim S, Lee H, Lee AY, Kim JM, Jo H, Song J, Ghim Y (2013) Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol 260:832–838PubMedCrossRefGoogle Scholar
  26. Kalla R, Spiegel R, Claassen J, Bardins S, Hahn A, Schneider E, Rettinger N, Glasauer S, Brandt T, Strupp M (2011) Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus. J Neuroophthalmol 31:320–325PubMedCrossRefGoogle Scholar
  27. Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE (2009) HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 40:3504–3510PubMedCrossRefGoogle Scholar
  28. Lee NH, Kwon HJ, Ban JH (2009) Analysis of residual symptoms after treatment in benign paroxysmal positional vertigo using questionnaire. Otolaryngol Head Neck Surg 141:232–236PubMedCrossRefGoogle Scholar
  29. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, Bisdorff A, Versino M, Evers S, Newman-Toker D (2012) Vestibular migraine: diagnostic criteria. J Vestib Res 22:167–172PubMedGoogle Scholar
  30. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, Bisdorff A, Versino M, Evers S, Newman-Toker DE (2013) Vestibuläre Migräne: diagnostische Kriterien: Konsensusdokument der Barany Society und der International Headache Society. Nervenarzt 84:511–516PubMedCrossRefGoogle Scholar
  31. Lezius F, Adrion C, Mansmann U, Jahn K, Strupp M (2011) High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière’s disease: a case series. Eur Arch Otorhinolaryngol 268:1237–1240PubMedCrossRefGoogle Scholar
  32. Matheson AJ, Darlington CL, Smith PF (1999) Dizziness in the elderly and age-related degeneration of the vestibular system. NZ J Psychol 28:10–16PubMedGoogle Scholar
  33. Minor LB, Solomon D, Zinreich JS, Zee DS (1998) Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal. Arch Otolaryngol Head Neck Surg 124:249–258PubMedCrossRefGoogle Scholar
  34. Neuhauser HK, Radtke A, von Brevern M, Lezius F, Feldmann M, Lempert T (2008) Burden of dizziness and vertigo in the community. Arch Intern Med 168:2118–2124PubMedCrossRefGoogle Scholar
  35. Novotný M, Kostrica R (2002) Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière’s disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 8:115–123PubMedGoogle Scholar
  36. Ogawa K, Suzuki Y, Oishi M, Kamei S, Shigihara S, Nomura Y (2013) Clinical study of medial area infarction in the region of posterior inferior cerebellar artery. J Stroke Cerebrovasc Dis 22:508–513PubMedCrossRefGoogle Scholar
  37. Okroglic S, Widmann CN, Urbach H, Scheltens P, Heneka MT (2013) Clinical symptoms and risk factors in cerebral microangiopathy patients. PLoS One 8:e53455 (Epub)PubMedCentralPubMedCrossRefGoogle Scholar
  38. Olsson LA, Hagnelius NO, Olsson H, Nilsson TK (2013) Subjective well-being in Swedish active seniors or seniors with cognitive complaints and its relation to commonly available biomarkers. Arch Gerontol Geriatr 56:303–308PubMedCrossRefGoogle Scholar
  39. Park JJ, Tang Y, Lopez I, Ishiyama A (2001) Age-related change in the number of neurons in the human vestibular ganglion. J Comp Neurol 431:437–443PubMedCrossRefGoogle Scholar
  40. Sander T, Sprenger A, Marti S, Naumann T, Straumann D, Helmchen C (2011) Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus. J Neurol 258:618–622PubMedCrossRefGoogle Scholar
  41. Scholtz AW, Steindl R, Burchardi N, Bognar-Steinberg I, Baumann W (2012) Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study. Clin Drug Investig 32:387–399PubMedCrossRefGoogle Scholar
  42. Schubert I, Küpper-Nybelen J, Ihle P, Thürmann P (2013) Prescribing potentially inappropriate medication (PIM) in Germany’s elderly as indicated by the PRISCUS list. An analysis based on regional claims data. Pharmacoepidemiol Drug Saf 22:719–727 (Apr 12 Epub)PubMedCrossRefGoogle Scholar
  43. Seok JI, Lee HM, Yoo JH, Lee DK (2008) Residual dizziness after successful repositioning treatment in patients with benign paroxysmal positional vertigo. J Clin Neurol 4:107–110PubMedCentralPubMedCrossRefGoogle Scholar
  44. Siebert S, Elkeles B, Hempel G, Kruse J, Smollich M (2013) Die PRISCUS-Liste im klinischen Test. Praktikabilität und Vergleich mit internationalen PIM-Listen. Z Gerontol Geriatr 46:35–47PubMedCrossRefGoogle Scholar
  45. Spiegel R, Rettinger N, Kalla R, Lehnen N, Straumann D, Brandt T, Glasauer S, Strupp M (2009) The intensity of downbeat nystagmus during daytime. Ann N Y Acad Sci 1164:293–299PubMedCrossRefGoogle Scholar
  46. Strupp M, Arbusow V, Maag KP, Gall C, Brandt T (1998) Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis. Neurology 51:838–844PubMedCrossRefGoogle Scholar
  47. Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K, Zingler VC, Mansmann U, Brandt T (2008) Long-term prophylactic treatment of attacks of vertigo in Menière’s disease – comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 128:520–524PubMedCrossRefGoogle Scholar
  48. Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, Bense S, Theil D, Jahn K, Brandt T (2004) Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 351:354–361PubMedCrossRefGoogle Scholar
  49. Teggi R, Giordano L, Bondi S, Fabiano B, Bussi M (2011) Residual dizziness after successful repositioning maneuvers for idiopathic benign paroxysmal positional vertigo in the elderly. Eur Arch Otorhinolaryngol 268:507–511PubMedCrossRefGoogle Scholar
  50. von Campe G, Regli F, Bogousslavsky J (2003) Heralding manifestations of basilar artery occlusion with lethal or severe stroke. J Neurol Neurosurg Psychiatry 74:1621–1626CrossRefGoogle Scholar
  51. Waldfahrer F (2008) Medikamentöse Prophylaxe von Kinetosen. In: Scherer H (Hrsg) Der Gleichgewichtssinn. Neues aus Forschung und Klinik. 6. Hennig Symposium. Springer, Wien, S 135–147CrossRefGoogle Scholar
  52. Waldfahrer F (2010) Pharmakotherapie vestibulärer Erkrankungen. In: Plinkert PK, Klingmann C (Hrsg) Hören und Gleichgewicht im Blick des gesellschaftlichen Wandels. 7. Hennig Symposium. Springer, Wien, S 103–113Google Scholar
  53. Waldfahrer F (2011a) Evidenz basierte Schwindeltherapie. In: Iro H, Waldfahrer F (Hrsg) Vertigo – Kontroverses und Bewährtes. 8. Hennig Symposium. Springer, Wien, S 197–203CrossRefGoogle Scholar
  54. Waldfahrer F (2011b) Repetitorium Neurotologie. In: Iro H, Waldfahrer F (Hrsg) Vertigo – Kontroverses und Bewährtes. 8. Hennig Symposium. Springer, Wien, S 207–244Google Scholar
  55. Walther LE, Nikolaus T, Schaaf H, Hörmann K (2008a) Schwindel und Stürze im Alter. Teil 1: Epidemiologie, Pathophysiologie, vestibulare Diagnostik und Sturzrisiko. HNO 56:833–841PubMedCrossRefGoogle Scholar
  56. Walther LE, Nikolaus T, Schaaf H, Hörmann K (2008b) Schwindel und Stürze im Alter: Teil 2: Sturzdiagnostik, Prophylaxe und Therapie. HNO 56:927–936PubMedCrossRefGoogle Scholar
  57. Walther LE, Westhofen M (2007) Presbyvertigo-aging of otoconia and vestibular sensory cells. J Vestib Res 17:89–92PubMedGoogle Scholar
  58. Weikert S, Rotter A, Scherer H, Hölzl M (2008) Picrotoxin in der Therapie des Morbus Meniere. Laryngorhinootologie 87:862–866PubMedCrossRefGoogle Scholar
  59. Yardley L, Beech S, Zander L, Evans T, Weinman J (1998) A randomized controlled trial of exercise therapy for dizziness and vertigo in primary care. Br J Gen Pract 48:1136–1140PubMedCentralPubMedGoogle Scholar
  60. Yoon GJ, Kim JT, Chang J, Kim DE, Cho BH, Lee JH, Jung HJ, Lee SH, Choi SM, Park MS, Cho KH (2012) Right-to-left shunts as a cause of juxtacortical spots in patients with migraine. Eur J Neurol 19:1086–1092PubMedCrossRefGoogle Scholar
  61. Zhang Y, Chapman AM, Plested M, Jackson D, Purroy F (2012) The Incidence, Prevalence, and Mortality of Stroke in France, Germany, Italy, Spain, the UK, and the US: A Literature Review. Stroke Res Treat 2012:436125 (Mar 1 Epub)PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2014

Authors and Affiliations

  1. 1.Neurologische KlinikKreiskliniken Altötting-BurghausenAltöttingDeutschland
  2. 2.Hals-Nasen-Ohren-Klinik, Kopf- und HalschirurgieUniversitätsklinikum ErlangenErlangenDeutschland

Personalised recommendations